These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24040574)

  • 1. Frequencies of Functional Polymorphisms in Three Pharmacokinetic Genes of Clinical Interest within the Admixed Puerto Rican Population.
    Orengo-Mercado C; Nieves B; López L; Vallés-Ortiz N; Renta JY; Santiago-Borrero PJ; Cadilla CL; Duconge J
    J Pharmacogenomics Pharmacoproteomics; 2013 Mar; 4(113):. PubMed ID: 24040574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical Relevant Polymorphisms Affecting Clopidogrel Pharmacokinetics and Pharmacodynamics: Insights from the Puerto Rico Newborn Screening Program.
    Hernandez-Suarez DF; Tomassini-Fernandini JC; Cuevas A; Rosario-Berrios AN; Nuñez-Medina HJ; Padilla-Arroyo D; Rivera N; Liriano J; Vega-Roman RK; Renta JY; Melin K; Duconge J
    Int J Environ Res Public Health; 2018 May; 15(6):. PubMed ID: 29848980
    [No Abstract]   [Full Text] [Related]  

  • 3. Genetic variants of the drug-metabolizing enzyme CYP2D6 in Puerto Rican psychiatry patients: a preliminary report and potential implications for breast cancer patients.
    González-Tejera G; Gaedigk A; Corey S
    P R Health Sci J; 2010 Sep; 29(3):299-304. PubMed ID: 20799519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiogenomic analysis of the Puerto Rican population.
    Ruaño G; Duconge J; Windemuth A; Cadilla CL; Kocherla M; Villagra D; Renta J; Holford T; Santiago-Borrero PJ
    Pharmacogenomics; 2009 Apr; 10(4):565-77. PubMed ID: 19374515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacogenetics of healthy volunteers in Puerto Rico.
    Claudio-Campos K; Orengo-Mercado C; Renta JY; Peguero M; García R; Hernández G; Corey S; Cadilla CL; Duconge J
    Drug Metab Pers Ther; 2015 Dec; 30(4):239-49. PubMed ID: 26501165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discovery of the nonfunctional CYP2D6 31 allele in Spanish, Puerto Rican, and US Hispanic populations.
    Gaedigk A; Isidoro-García M; Pearce RE; Sánchez S; García-Solaesa V; Lorenzo-Romo C; Gonzalez-Tejera G; Corey S
    Eur J Clin Pharmacol; 2010 Sep; 66(9):859-64. PubMed ID: 20473659
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allele and genotype frequencies of CYP2C9, CYP2C19 and CYP2D6 in an Italian population.
    Scordo MG; Caputi AP; D'Arrigo C; Fava G; Spina E
    Pharmacol Res; 2004 Aug; 50(2):195-200. PubMed ID: 15177309
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C9 and VKORC1 genotypes in Puerto Ricans: A case for admixture-matching in clinical pharmacogenetic studies.
    Villagra D; Duconge J; Windemuth A; Cadilla CL; Kocherla M; Gorowski K; Bogaard K; Renta JY; Cruz IA; Mirabal S; Seip RL; Ruaño G
    Clin Chim Acta; 2010 Sep; 411(17-18):1306-11. PubMed ID: 20488169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CYP2C9, CYPC19 and CYP2D6 gene profiles and gene susceptibility to drug response and toxicity in Turkish population.
    Arici M; Özhan G
    Saudi Pharm J; 2017 Mar; 25(3):376-380. PubMed ID: 28344492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interethnic Variability in CYP2D6, CYP2C9, and CYP2C19 Genes and Predicted Drug Metabolism Phenotypes Among 6060 Ibero- and Native Americans: RIBEF-CEIBA Consortium Report on Population Pharmacogenomics.
    Naranjo MG; Rodrigues-Soares F; Peñas-Lledó EM; Tarazona-Santos E; Fariñas H; Rodeiro I; Terán E; Grazina M; Moya GE; López-López M; Sarmiento AP; Calzadilla LR; Ramírez-Roa R; Ortiz-López R; Estévez-Carrizo FE; Sosa-Macías M; Barrantes R; LLerena A;
    OMICS; 2018 Sep; 22(9):575-588. PubMed ID: 30183544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacogenetic relevant polymorphisms of CYP2C9, CYP2C19, CYP2D6, and CYP3A5 in Bhutanese population.
    Dorji PW; Wangchuk S; Boonprasert K; Tarasuk M; Na-Bangchang K
    Drug Metab Pers Ther; 2019 Dec; 34(4):. PubMed ID: 32004143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CYP2D6 genotypes in Puerto Rican psychiatry patients with intolerance of antidepressants and antipsychotics.
    Gonzalez-Tejera GM; Corey S
    Bol Asoc Med P R; 2009; 101(1):7-12. PubMed ID: 19954080
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphisms of CYP2C19 and CYP2D6 in Israeli ethnic groups.
    Luo HR; Aloumanis V; Lin KM; Gurwitz D; Wan YJ
    Am J Pharmacogenomics; 2004; 4(6):395-401. PubMed ID: 15651900
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of CYP2D6 and CYP2C19 polymorphisms associated with poor metabolizer phenotype in five Amerindian groups and western Mestizos from Mexico.
    Salazar-Flores J; Torres-Reyes LA; Martínez-Cortés G; Rubi-Castellanos R; Sosa-Macías M; Muñoz-Valle JF; González-González C; Ramírez A; Román R; Méndez JL; Barrera A; Torres A; Medina R; Rangel-Villalobos H
    Genet Test Mol Biomarkers; 2012 Sep; 16(9):1098-104. PubMed ID: 22913530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization CYP1A2, CYP2C9, CYP2C19 and CYP2D6 Polymorphisms Using HRMA in Psychiatry Patients with Schizophrenia and Bipolar Disease for Personalized Medicine.
    Yenilmez ED; Tamam L; Karaytug O; Tuli A
    Comb Chem High Throughput Screen; 2018; 21(5):374-380. PubMed ID: 29921201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Defining screening panel of functional variants of CYP1A1, CYP2C9, CYP2C19, CYP2D6, and CYP3A4 genes in Serbian population.
    Skadrić I; Stojković O
    Int J Legal Med; 2020 Mar; 134(2):433-439. PubMed ID: 31858263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Population stratification confounds genetic association studies among Latinos.
    Choudhry S; Coyle NE; Tang H; Salari K; Lind D; Clark SL; Tsai HJ; Naqvi M; Phong A; Ung N; Matallana H; Avila PC; Casal J; Torres A; Nazario S; Castro R; Battle NC; Perez-Stable EJ; Kwok PY; Sheppard D; Shriver MD; Rodriguez-Cintron W; Risch N; Ziv E; Burchard EG;
    Hum Genet; 2006 Jan; 118(5):652-64. PubMed ID: 16283388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of CYP2C9*2, CYP2C19*2, and CYP2D6*4 polymorphisms in patients with type 2 diabetes mellitus.
    Semiz S; Dujic T; Ostanek B; Prnjavorac B; Bego T; Malenica M; Marc J; Causevic A
    Bosn J Basic Med Sci; 2010 Nov; 10(4):287-91. PubMed ID: 21108610
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.